Strides Arcolab to manufacture Calcitriol Softgel Capsules for US market

Following USFDA approval

Strides Arcolab announced that it has received approval from the United States Food & Drug Administration for Calcitriol Softgel Capsules, 0.25 mcg and 0.5 mcg.

The product will be manufactured at the Company's Oral dosage factory in Bangalore and marketed by Strides in the US market.

Powered by Capital Market - Live News